Xing Xue Chen
Director/Miembro de la Junta en CENTURY IRON AND STEEL INDUSTRIAL CO.,LTD. .
Fortuna: 22 M $ al 31/05/2024
Origen de la red de primer grado Xing Xue Chen.
| Entidad | Tipo de entidad | Industria | |
|---|---|---|---|
| Public Company | Building Products | 15 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Xing Xue Chen a través de su red personal
| Empresa | Sector | Personas relacionadas | Puesto principal |
|---|---|---|---|
| CENTURY WIND POWER CO., LTD. | Alternative Power Generation | Chairman Director/Board Member | |
| FARCENT ENTERPRISE CO.,LTD | Household/Personal Care | Director/Board Member | |
| YI CHUN GREEN TECHNOLOGY CO., LTD. | Environmental Services | Chairman | |
| TAIWAN GLASS IND. CORP. | Industrial Specialties | Director/Board Member | |
| National Taiwan University | College/University | Graduate Degree | |
| FORMOSA TAFFETA CO., LTD. | Textiles | Chief Executive Officer | |
| KENDA RUBBER INDUSTRIAL CO. LTD. | Automotive Aftermarket | Director/Board Member | |
| SWANCOR HOLDING CO., LTD. | Chemicals: Specialty | Director/Board Member | |
| National Chung Hsing University | College/University | Undergraduate Degree | |
UWELL Biopharma, Inc.
 UWELL Biopharma, Inc. Pharmaceuticals: MajorHealth Technology UWELL Biopharma, Inc. is a biotech company founded in 2003 and based in New Taipei, Taiwan. The Taiwanese company specializes in developing new cancer drugs using chimeric antigen receptor T-cell (CAR-T) technology. CAR-T therapy involves engineering a patient's T-cells to recognize and attack cancer cells. UWELL is currently conducting an open, single-center phase I clinical trial to evaluate the safety and efficacy of its anti-CD19 CAR-T cell injection in patients with relapsed or refractory B-cell non-Hodgkin's lymphoma. The study has been approved by the Institutional Review Board of Tri-Service General Hospital and the Ministry of Health and Welfare. UWELL has achieved success in treating adult blood cancer patients with CAR-T therapy, as evidenced by the clearance of cancer cells in the first case treated at Tri-Service General Hospital. | Pharmaceuticals: Major | Director/Board Member | |
Yi-Chiu International Development Co. Ltd.
 Yi-Chiu International Development Co. Ltd. Financial ConglomeratesFinance Yi-Chiu International Development Co. Ltd. is a Taiwanese company that provides investment and management consulting services. The private company is based in New Taipei, Taiwan. The company was founded in 2012. | Financial Conglomerates | Director/Board Member | |
| CHINA STEEL CORPORATION | Steel | Director/Board Member | |
| Yi Chou Group | Chairman | ||
| University of Tamkang | College/University | Undergraduate Degree | |
| NORTH-STAR INTERNATIONAL CO., LTD. | Specialty Stores | Director/Board Member | |
Century Huaxin Wind Energy Co. Ltd.
 Century Huaxin Wind Energy Co. Ltd. SteelNon-Energy Minerals Century Huaxin Wind Energy Co. Ltd. is a Taiwanese company that engages in iron and steel processing. The private company is based in Taoyuan City, Taiwan. The company was founded in 2020. The CEO is Kuo Chih Huang. | Steel | Director/Board Member | |
| Hsiang Feng Investment Co., Ltd. | Director/Board Member | ||
| HSIN KUANG STEEL COMPANY LIMITED | Steel | Chief Executive Officer | |
| SIMULA TECHNOLOGY INC. | Electronic Components | Director/Board Member |
Estadísticas
Internacional
| Taiwán | 20 |
Sectorial
| Process Industries | 4 |
| Consumer Services | 4 |
| Non-Energy Minerals | 4 |
| Utilities | 2 |
| Consumer Non-Durables | 2 |
Operativa
| Director/Board Member | 24 |
| Independent Dir/Board Member | 9 |
| Chief Executive Officer | 5 |
| Chairman | 5 |
| Public Communications Contact | 3 |
Las relaciones más conectadas
- Bolsa de valores
- Insiders
- Xing Xue Chen
- Conexiones Empresas
